AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34747338 — intervention group
Group type: EXPERIMENTAL
Intervention: Fecal microbiota transplant (FMT)
Number of subjects: 0
Study 35080598 — intervention group
Group type: COMPARATOR
Intervention: Taper to placebo (taper group)
Number of subjects: 101
Study 35080598 — intervention group
Group type: EXPERIMENTAL
Intervention: Continue SRI (continuation group)
Number of subjects: 101
Study 34302145 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug repositioning approaches
Number of subjects: 0
Study 34302145 — intervention group
Group type: EXPERIMENTAL
Intervention: Common variant genetics
Number of subjects: 0
Study 34302145 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcriptome-wide association studies
Number of subjects: 0
Study 34302145 — intervention group
Group type: EXPERIMENTAL
Intervention: Gene-set association
Number of subjects: 0
Study 34302145 — intervention group
Group type: EXPERIMENTAL
Intervention: Causal inference by Mendelian randomization
Number of subjects: 0
Study 34302145 — intervention group
Group type: EXPERIMENTAL
Intervention: Polygenic scoring
Number of subjects: 0
Study 32573782 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 64
Study 32573782 — intervention group
Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 64
Study 35363627 — intervention group
Group type: EXPERIMENTAL
Intervention: Erlotinib 100 mg/d
Number of subjects: 9
Study 35363627 — intervention group
Group type: EXPERIMENTAL
Intervention: Erlotinib 50 mg/d
Number of subjects: 9
Study 35363627 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 33564986 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe/very severe pain
Number of subjects: 2310
Study 33564986 — intervention group
Group type: COMPARATOR
Intervention: No pain
Number of subjects: 2310
Study 33564986 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain severity (general)
Number of subjects: 2310
Study 32853116 — intervention group
Group type: COMPARATOR
Intervention: Muscle-directed stretching
Number of subjects: 60
Study 32853116 — intervention group
Group type: COMPARATOR
Intervention: Nerve-directed stretching
Number of subjects: 60
Study 35263519 — intervention group
Group type: EXPERIMENTAL
Intervention: Ribociclib plus letrozole
Number of subjects: 668
Study 35263519 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus letrozole
Number of subjects: 668
Study 32234739 — intervention group
Group type: EXPERIMENTAL
Intervention: CytoSorb haemoadsorber
Number of subjects: 25
Study 35616594 — intervention group
Group type: EXPERIMENTAL
Intervention: LPS administration
Number of subjects: 10
Study 35616594 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 32554514 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab 3 mg/kg plus nab‐paclitaxel 125 mg/m2 and gemcitabine 1,000 mg/m2
Number of subjects: 50
Study 32554514 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab plus nab‐paclitaxel and gemcitabine
Number of subjects: 50
Study 33678201 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral Nutritional Supplements (ONS)
Number of subjects: 409
Study 33678201 — intervention group
Group type: COMPARATOR
Intervention: Routine Care (Control)
Number of subjects: 409
Study 33773565 — intervention group
Group type: EXPERIMENTAL
Intervention: Levonorgestrel intrauterine system plus metformin (500mg twice daily)
Number of subjects: 51
Study 33773565 — intervention group
Group type: COMPARATOR
Intervention: Levonorgestrel intrauterine system only
Number of subjects: 51
Study 32135005 — intervention group
Group type: EXPERIMENTAL
Intervention: Singing and dancing
Number of subjects: 21
Study 32135005 — intervention group
Group type: COMPARATOR
Intervention: Dancing only
Number of subjects: 21
Study 32135005 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal aerobic capacity test
Number of subjects: 21
Study 36213713 — intervention group
Group type: EXPERIMENTAL
Intervention: Provision of information and supportive nursing care
Number of subjects: 60
Study 36213713 — intervention group
Group type: COMPARATOR
Intervention: Control group (no provision of information and supportive nursing care)
Number of subjects: 60
Study 33862407 — intervention group
Group type: EXPERIMENTAL
Intervention: VR-ABM
Number of subjects: 108
Study 33862407 — intervention group
Group type: COMPARATOR
Intervention: VR-control
Number of subjects: 108
Study 33574155 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous acellular sterile filtered amniotic fluid
Number of subjects: 100
Study 32020170 — intervention group
Group type: EXPERIMENTAL
Intervention: Puregraft fat and 0.5 × 10^6 ADRCs/cm2 scalp
Number of subjects: 71
Study 32020170 — intervention group
Group type: EXPERIMENTAL
Intervention: Puregraft fat and 1.0 × 10^6 ADRCs/cm2 scalp
Number of subjects: 71
Study 32020170 — intervention group
Group type: EXPERIMENTAL
Intervention: Puregraft fat alone
Number of subjects: 71
Study 32020170 — intervention group
Group type: COMPARATOR
Intervention: Saline control
Number of subjects: 71
Study 35347394 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypocaloric legume-based DASH diet
Number of subjects: 300
Study 35347394 — intervention group
Group type: COMPARATOR
Intervention: Hypocaloric DASH diet
Number of subjects: 300
Study 34932772 — intervention group
Group type: EXPERIMENTAL
Intervention: Auriculotherapy (AT)
Number of subjects: 36
Study 34932772 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 36
Study 35040600 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab (5 mg/kg) administered intraperitoneally for 4 weeks
Number of subjects: 4
Study 35040600 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 4
Study 32128971 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-transplant exercise
Number of subjects: 0
Study 32128971 — intervention group
Group type: COMPARATOR
Intervention: Exercise intervention
Number of subjects: 0
Study 36106542 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab (TCZ) 162 mg every week for 24 weeks
Number of subjects: 23
Study 36106542 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 34127039 — intervention group
Group type: EXPERIMENTAL
Intervention: Seated lumbar rotation manipulation
Number of subjects: 60
Study 34127039 — intervention group
Group type: COMPARATOR
Intervention: Lumbar traction in supine position
Number of subjects: 60
Study 32505770 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnostic model for lung cancer based on platelet features
Number of subjects: 245
Study 32505770 — intervention group
Group type: COMPARATOR
Intervention: Diagnostic model for lung cancer
Number of subjects: 245
Study 32505770 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnostic model for colon cancer based on platelet features
Number of subjects: 245
Study 32505770 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnostic model for differentiating lung malignancy from benign diseases
Number of subjects: 245
Study 36307602 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-incision distal gastrectomy (SIDG)
Number of subjects: 83
Study 36307602 — intervention group
Group type: COMPARATOR
Intervention: Multiport laparoscopic distal gastrectomy (MLDG)
Number of subjects: 83
Study 33389280 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback device group
Number of subjects: 34
Study 33389280 — intervention group
Group type: COMPARATOR
Intervention: Self-directed breathing exercise group
Number of subjects: 34
Study 33389280 — intervention group
Group type: COMPARATOR
Intervention: Psychoeducation group
Number of subjects: 34
Study 35775513 — intervention group
Group type: EXPERIMENTAL
Intervention: Steri-Strips™
Number of subjects: 75
Study 35775513 — intervention group
Group type: COMPARATOR
Intervention: Subcuticular suturing
Number of subjects: 75
Study 34586931 — intervention group
Group type: EXPERIMENTAL
Intervention: Prognostic nomogram based on SOFA
Number of subjects: 5240
Study 34586931 — intervention group
Group type: COMPARATOR
Intervention: SOFA model
Number of subjects: 5240
Study 32830635 — intervention group
Group type: EXPERIMENTAL
Intervention: Xenon light source
Number of subjects: 64
Study 32830635 — intervention group
Group type: COMPARATOR
Intervention: Light-emitting diode
Number of subjects: 64
Study 34080304 — intervention group
Group type: EXPERIMENTAL
Intervention: SBC-based nursing intervention
Number of subjects: 82
Study 33773969 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial intelligence model using chest x-rays and clinical data for severity prediction
Number of subjects: 1834
Study 33773969 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep-learning features combined with clinical data for progression prediction
Number of subjects: 1834
Study 33773969 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined image and clinical data model
Number of subjects: 1834
Study 35279917 — intervention group
Group type: EXPERIMENTAL
Intervention: Unpleasant olfactory and gustatory stimuli
Number of subjects: 22
Study 35279917 — intervention group
Group type: COMPARATOR
Intervention: Pleasant and neutral stimuli
Number of subjects: 22
Study 34319510 — intervention group
Group type: EXPERIMENTAL
Intervention: UC-MSC treatment (1-2 × 10^6 per kilogram)
Number of subjects: 210
Study 32295417 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine 1.8 mg
Number of subjects: 714
Study 36351563 — intervention group
Group type: EXPERIMENTAL
Intervention: aPDT (methylene blue-mediated)
Number of subjects: 83
Study 36351563 — intervention group
Group type: COMPARATOR
Intervention: Chlorhexidine gargle
Number of subjects: 83
Study 36351563 — intervention group
Group type: COMPARATOR
Intervention: Normal saline rinse
Number of subjects: 83
Study 34610135 — intervention group
Group type: EXPERIMENTAL
Intervention: mOPV2
Number of subjects: 621
Study 33130935 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-loaded single-row technique
Number of subjects: 50
Study 33130935 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-loaded single-row technique
Number of subjects: 50
Study 35004547 — intervention group
Group type: EXPERIMENTAL
Intervention: Online self-control training added to multidisciplinary obesity treatment (MOT) program
Number of subjects: 259
Study 35004547 — intervention group
Group type: COMPARATOR
Intervention: Sham training added to multidisciplinary obesity treatment (MOT) program
Number of subjects: 259
Study 35863864 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline dactylitis (LDI>0)
Number of subjects: 851
Study 35863864 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline nail disease (mNAPSI >1)
Number of subjects: 851
Study 35863864 — intervention group
Group type: COMPARATOR
Intervention: Baseline enthesitis (SPARCC EI>0 or LEI>0)
Number of subjects: 851
Study 34308545 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive stimulation intervention (88 individual sessions, 45 minutes each, twice per week)
Number of subjects: 82
Study 34308545 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 82
Study 35324509 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy for insomnia
Number of subjects: 112
Study 35324509 — intervention group
Group type: COMPARATOR
Intervention: HF self-management education (attention control)
Number of subjects: 112
Study 33651291 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycorrhizal treatments (Funneliformis mosseae and Claroideoglomus etunicatum)
Number of subjects: 3
Study 33651291 — intervention group
Group type: COMPARATOR
Intervention: Control (no mycorrhiza)
Number of subjects: 3
Study 32738465 — intervention group
Group type: EXPERIMENTAL
Intervention: HypoRT with ADT (60 Gy/20 fractions to prostate, 44 Gy to nodal areas)
Number of subjects: 105
Study 32738465 — intervention group
Group type: EXPERIMENTAL
Intervention: HypoRT with ADT
Number of subjects: 105
Study 34247160 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral frailty measures program (12 weeks)
Number of subjects: 83
Study 34247160 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 83
Study 616280550 — intervention group
Group type: EXPERIMENTAL
Intervention: NRB (non-rebreather mask) with flush rate oxygen (>40 L/min)
Number of subjects: 30
Study 616280550 — intervention group
Group type: EXPERIMENTAL
Intervention: BVM (bag-valve-mask) with flush rate oxygen
Number of subjects: 30
Study 616280550 — intervention group
Group type: EXPERIMENTAL
Intervention: BVM with simulated mask leak
Number of subjects: 30
Study 616280550 — intervention group
Group type: COMPARATOR
Intervention: NRB vs BVM
Number of subjects: 30
Study 34210841 — intervention group
Group type: EXPERIMENTAL
Intervention: Universal screening for depression in adolescents
Number of subjects: 10000
Study 34210841 — intervention group
Group type: COMPARATOR
Intervention: Assessment as usual
Number of subjects: 10000
Study 34024526 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual energy supply based on indirect calorimetry (IC group, n = 9)
Number of subjects: 20
Study 34024526 — intervention group
Group type: COMPARATOR
Intervention: Standard energy supply based on a formula (SC group, n = 11)
Number of subjects: 20
Study 33124984 — intervention group
Group type: EXPERIMENTAL
Intervention: Thought Spot app
Number of subjects: 481
Study 33124984 — intervention group
Group type: COMPARATOR
Intervention: Usual care (mental health services information pamphlet)
Number of subjects: 481
Study 36273223 — intervention group
Group type: EXPERIMENTAL
Intervention: VR entertainment 3 times per week during inpatient rehabilitation
Number of subjects: 30
Study 36273223 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 30
Study 32182353 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily cash incentives
Number of subjects: 274
Study 32182353 — intervention group
Group type: COMPARATOR
Intervention: Action planning
Number of subjects: 274
Study 32182353 — intervention group
Group type: EXPERIMENTAL
Intervention: Charity incentives
Number of subjects: 274
Study 32182353 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-monitoring prompts
Number of subjects: 274
Study 32182353 — intervention group
Group type: EXPERIMENTAL
Intervention: Coping planning
Number of subjects: 274
Study 34378853 — intervention group
Group type: EXPERIMENTAL
Intervention: Tapered Implants (TIs)
Number of subjects: 48
Study 34378853 — intervention group
Group type: COMPARATOR
Intervention: Straight Implants (SIs)
Number of subjects: 48
Study 34378853 — intervention group
Group type: EXPERIMENTAL
Intervention: Tapered Implants (TIs) and Straight Implants (SIs)
Number of subjects: 48
Study 32931412 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg iron supplementation
Number of subjects: 44
Study 32931412 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mg iron supplementation
Number of subjects: 44
Study 32931412 — intervention group
Group type: COMPARATOR
Intervention: No iron supplementation
Number of subjects: 44
Study 32931412 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 36282854 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-mediated play-based intervention (10-week duration)
Number of subjects: 29
Study 36282854 — intervention group
Group type: COMPARATOR
Intervention: Waitlisted control group (10-week wait)
Number of subjects: 29
Study 35451117 — intervention group
Group type: EXPERIMENTAL
Intervention: Water exchange colonoscopy with infused water volume during insertion ≥ 1000 mL
Number of subjects: 912
Study 35451117 — intervention group
Group type: EXPERIMENTAL
Intervention: Water exchange colonoscopy
Number of subjects: 912
Study 33131095 — intervention group
Group type: EXPERIMENTAL
Intervention: Tegoprazan 50 mg
Number of subjects: 100
Study 33131095 — intervention group
Group type: COMPARATOR
Intervention: Revaprazan 200 mg
Number of subjects: 100
Study 35302633 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate card acquisition group
Number of subjects: 186
Study 35302633 — intervention group
Group type: COMPARATOR
Intervention: Delayed card acquisition group
Number of subjects: 186
Study 32052748 — intervention group
Group type: EXPERIMENTAL
Intervention: Music intervention
Number of subjects: 126
Study 32052748 — intervention group
Group type: COMPARATOR
Intervention: Non-music control
Number of subjects: 126
Study 35504234 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketogenic medium chain triglyceride (kMCT) intervention
Number of subjects: 32
Study 35504234 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 32921535 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% Chlorhexidine (CHG) bathing daily during the intervention period (n = 1501)
Number of subjects: 4799
Study 32921535 — intervention group
Group type: COMPARATOR
Intervention: Standard care without CHG bathing during the same period (n = 3299)
Number of subjects: 4799
Study 35835631 — intervention group
Group type: EXPERIMENTAL
Intervention: Total parenteral nutrition and some control of the obstruction
Number of subjects: 20
Study 35835631 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment of the obstruction only
Number of subjects: 20
Study 35835631 — intervention group
Group type: EXPERIMENTAL
Intervention: Untreated tumour, obstruction and starvation
Number of subjects: 20
Study 32925679 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D fluoroscopy-based navigation (NAV)
Number of subjects: 41
Study 32925679 — intervention group
Group type: COMPARATOR
Intervention: Conventional 2D fluoroscopy (FLUORO)
Number of subjects: 41
Study 33413161 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-volume month (November 2017)
Number of subjects: 1470
Study 33413161 — intervention group
Group type: COMPARATOR
Intervention: High-volume month (August 2017)
Number of subjects: 1470
Study 32716492 — intervention group
Group type: EXPERIMENTAL
Intervention: Genome-wide association study
Number of subjects: 100000
Study 32716492 — intervention group
Group type: EXPERIMENTAL
Intervention: Mendelian randomization
Number of subjects: 100000
Study 34724587 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS (2 mA for 15 min)
Number of subjects: 15
Study 34724587 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 15
Study 33858205 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroid (CS) injection: 20 mg of triamcinolone
Number of subjects: 186
Study 33858205 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid (HA) injection: 2.5 mL of HA
Number of subjects: 186
Study 33858205 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (NS) injection: 2.5 mL of NS
Number of subjects: 186
Study 34132328 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted high serum copper levels
Number of subjects: 5548
Study 34132328 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted high serum zinc levels
Number of subjects: 5548
Study 34888600 — intervention group
Group type: EXPERIMENTAL
Intervention: EDC in water (group S)
Number of subjects: 64
Study 34888600 — intervention group
Group type: EXPERIMENTAL
Intervention: EDC in ethanol (group Sa)
Number of subjects: 64
Study 34888600 — intervention group
Group type: COMPARATOR
Intervention: EDC in water (group S), EDC in ethanol (group E), EDC in acetone (group B)
Number of subjects: 64
Study 34888600 — intervention group
Group type: COMPARATOR
Intervention: Aging groups (S0a, Sa, Ea, Ba)
Number of subjects: 64
Study 34888600 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 64
Study 35240044 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (300 mg bolus)
Number of subjects: 663
Study 35240044 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-dose unfractionated heparin (5000 IU bolus followed by 1250 IU/h for 6 h)
Number of subjects: 663
Study 35240044 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose unfractionated heparin (5000 IU bolus followed by 500 IU/h for 6 h)
Number of subjects: 663
Study 35240044 — intervention group
Group type: COMPARATOR
Intervention: No aspirin
Number of subjects: 663
Study 35240044 — intervention group
Group type: COMPARATOR
Intervention: No unfractionated heparin
Number of subjects: 663
Study 35913722 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-shot lumbar erector spinae plane block (ESPB) at L1
Number of subjects: 71
Study 35913722 — intervention group
Group type: COMPARATOR
Intervention: No block (control)
Number of subjects: 71
Study 33795826 — intervention group
Group type: EXPERIMENTAL
Intervention: HA-PCI (hippocampus-avoidance prophylactic cranial irradiation)
Number of subjects: 106
Study 33795826 — intervention group
Group type: COMPARATOR
Intervention: C-PCI (conventional prophylactic cranial irradiation)
Number of subjects: 106
Study 33795826 — intervention group
Group type: EXPERIMENTAL
Intervention: HA-PCI
Number of subjects: 106
Study 33795826 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher thoracic radiotherapy dose (≥ 60 Gy)
Number of subjects: 106
Study 32819447 — intervention group
Group type: EXPERIMENTAL
Intervention: Daratumumab plus bortezomib/dexamethasone (D‐Vd)
Number of subjects: 498
Study 32819447 — intervention group
Group type: COMPARATOR
Intervention: Bortezomib/dexamethasone (Vd)
Number of subjects: 498
Study 35219526 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitomycin drops
Number of subjects: 52
Study 35219526 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 34416369 — intervention group
Group type: EXPERIMENTAL
Intervention: Trazodone
Number of subjects: 1224
Study 34416369 — intervention group
Group type: EXPERIMENTAL
Intervention: Eszopiclone
Number of subjects: 1224
Study 34416369 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 1224
Study 34416369 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1224
Study 36265571 — intervention group
Group type: EXPERIMENTAL
Intervention: Intact cord resuscitation
Number of subjects: 0
Study 36265571 — intervention group
Group type: COMPARATOR
Intervention: Clamped cord resuscitation
Number of subjects: 0
Study 34179723 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac
Number of subjects: 20
Study 34179723 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 34179723 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Ketorolac and Placebo)
Number of subjects: 20
Study 32392019 — intervention group
Group type: EXPERIMENTAL
Intervention: Early neuromuscular blockade in mechanically ventilated patients with moderate/severe ARDS
Number of subjects: 79
Study 36176003 — intervention group
Group type: EXPERIMENTAL
Intervention: VLC-NDPP
Number of subjects: 300
Study 36176003 — intervention group
Group type: COMPARATOR
Intervention: NDPP
Number of subjects: 300